Medican Enterprises Stock Net Income
| MDCN Stock | USD 0.0001 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medican Enterprises, as well as the relationship between them.
Medican Enterprises' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medican Enterprises' valuation are provided below:Medican Enterprises does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Medican |
Medican Enterprises 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medican Enterprises' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medican Enterprises.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Medican Enterprises on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Medican Enterprises or generate 0.0% return on investment in Medican Enterprises over 90 days. Medican Enterprises is related to or competes with Ecc Cap. Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and r... More
Medican Enterprises Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medican Enterprises' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medican Enterprises upside and downside potential and time the market with a certain degree of confidence.
Medican Enterprises Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medican Enterprises' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medican Enterprises' standard deviation. In reality, there are many statistical measures that can use Medican Enterprises historical prices to predict the future Medican Enterprises' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medican Enterprises' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medican Enterprises Backtested Returns
We have found three technical indicators for Medican Enterprises, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medican Enterprises are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Medican Enterprises has perfect predictability. Overlapping area represents the amount of predictability between Medican Enterprises time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medican Enterprises price movement. The serial correlation of 1.0 indicates that 100.0% of current Medican Enterprises price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Medican Enterprises reported net income of (56.52 Million). This is 122.69% lower than that of the Pharmaceuticals sector and 154.74% lower than that of the Health Care industry. The net income for all United States stocks is 109.9% higher than that of the company.
Medican Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medican Enterprises' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medican Enterprises could also be used in its relative valuation, which is a method of valuing Medican Enterprises by comparing valuation metrics of similar companies.Medican Enterprises is currently under evaluation in net income category among its peers.
Medican Fundamentals
| Return On Asset | -68.18 | |||
| Current Valuation | 7.77 M | |||
| Shares Outstanding | 134.8 M | |||
| Shares Owned By Institutions | 0.52 % | |||
| Price To Sales | 2.72 X | |||
| Net Income | (56.52 M) | |||
| Cash And Equivalents | 9.4 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.98 M) | |||
| Earnings Per Share | (17.92) X | |||
| Beta | 104.43 | |||
| Market Capitalization | 13.48 K | |||
| Total Asset | 112.62 K | |||
| Retained Earnings | (166.24 M) | |||
| Working Capital | (9.66 M) | |||
| Current Asset | 74 K | |||
| Current Liabilities | 9.74 M | |||
| Net Asset | 112.62 K |
About Medican Enterprises Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medican Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medican Enterprises using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medican Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Medican Enterprises
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medican Enterprises position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medican Enterprises will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Medican Enterprises could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medican Enterprises when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medican Enterprises - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medican Enterprises to buy it.
The correlation of Medican Enterprises is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medican Enterprises moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medican Enterprises moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medican Enterprises can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medican Pink Sheet
Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.